Physician profile
Peter A Blume
NPI 1376526814
$480,951.55
in general payments reported to CMS, 2019-2025
21 companies · $44K in 2025
The $44K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107K · 2020: $13K · 2021: $28K · 2022: $140K · 2023: $90K · 2024: $59K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $182K · Consulting Fee: $5,330 · Travel and Lodging: $4,554 · Food and Beverage: $1,139 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $182,292.52 |
| Consulting Fee | $5,330.00 |
| Travel and Lodging | $4,553.95 |
| Food and Beverage | $1,139.49 |
| Education | $156.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vilex LLC | $279,544.02 | 2019-2025 | Titanex |
| Bioventus LLC | $91,196.29 | 2019-2022 | |
| Orthofix Medical, INC. | $77,920.72 | 2019-2024 | Oscar Pro |
| Stryker Corporation | $17,312.00 | 2019-2023 | Citrefix |
| Gramercy Extremity Orthopedics LLC | $7,715.45 | 2019-2024 | |
| Osiris Therapeutics INC. | $4,875.21 | 2019 | |
| International Life Sciences | $584.07 | 2023 | |
| Smith+Nephew, INC. | $555.36 | 2019-2024 | Evos, Peri-Loc, Salto Talaris Total Ankle Prosthesis |
| Misonix INC | $322.68 | 2019-2021 | |
| Bone Support INC. | $200.00 | 2020 | |
| Wright Medical Technology, INC. | $175.29 | 2019 | |
| Organogenesis INC. | $115.50 | 2019 | |
| Abbvie INC. | $99.81 | 2019 | |
| Royal Biologics, INC. | $93.89 | 2020 | |
| Polaris Technology Solutions LLC | $92.30 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $80.75 | 2019 | |
| Treace Medical Concepts, INC. | $28.57 | 2025 | |
| Hydrofera LLC | $21.93 | 2025 | Cutimed Sorbion |
| Djo, LLC | $17.71 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,975,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Blume listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.